Home Cart Sign in  
Chemical Structure| 1320288-19-4 Chemical Structure| 1320288-19-4

Structure of UNC 0631
CAS No.: 1320288-19-4

Chemical Structure| 1320288-19-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

UNC 0631 is a potent G9a inhibitor with IC50 value of 4 nM.

Synonyms: UNC 0631

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of UNC 0631

CAS No. :1320288-19-4
Formula : C37H61N7O2
M.W : 635.93
SMILES Code : COC1=CC2=C(NC3CCN(CC4CCCCC4)CC3)N=C(N5CCN(C(C)C)CCC5)N=C2C=C1OCCCN6CCCCC6
Synonyms :
UNC 0631
MDL No. :MFCD22683862
InChI Key :XFAXSWXKPQWHDW-UHFFFAOYSA-N
Pubchem ID :53315868

Safety of UNC 0631

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of UNC 0631

epigenetics

Isoform Comparison

Biological Activity

Description
UNC 0631 is a potent inhibitor of histone methyltransferase G9a, with an IC50 of 4 nM. It effectively reduces H3K9me2 levels in MDA-MB-231 cells, with an IC50 of 25 nM [1].

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-231 0.025 µM (IC50) 48 hours Reduction of H3K9me2 levels, IC50 of 0.025 μM J Med Chem. 2011 Sep 8;54(17):6139-50.
HCT116 p53 −/− 0.072 µM (IC50) 48 hours Reduction of H3K9me2 levels, IC50 of 0.072 μM J Med Chem. 2011 Sep 8;54(17):6139-50.
HCT116 wt 0.051 µM (IC50) 48 hours Reduction of H3K9me2 levels, IC50 of 0.051 μM J Med Chem. 2011 Sep 8;54(17):6139-50.
22RV1 0.024 µM (IC50) 48 hours Reduction of H3K9me2 levels, IC50 of 0.024 μM J Med Chem. 2011 Sep 8;54(17):6139-50.
PC3 0.026 µM (IC50) 48 hours Reduction of H3K9me2 levels, IC50 of 0.026 μM J Med Chem. 2011 Sep 8;54(17):6139-50.
IMR90 0.046 µM (IC50) 48 hours Reduction of H3K9me2 levels, IC50 of 0.046 μM J Med Chem. 2011 Sep 8;54(17):6139-50.
MCF7 0.018 µM (IC50) 48 hours Reduction of H3K9me2 levels, IC50 of 0.018 μM J Med Chem. 2011 Sep 8;54(17):6139-50.
CD14+ monocytes 160 nM 8 days UNC 0631 alleviated the CyaA-elicited block of monocyte differentiation to macrophages by inhibiting G9a methyltransferase activity. mBio. 2025 Apr 9;16(4):e0013825

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.57mL

0.31mL

0.16mL

7.86mL

1.57mL

0.79mL

15.73mL

3.15mL

1.57mL

References

 

Historical Records

Categories